Healthcare - Biotechnology - NASDAQ - US
$ 0.99
-5.71 %
$ 75.1 M
Market Cap
-2.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
73.43%
EBIT
Estimate
--24.58%
Net Income
Estimate
19.82%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Clearside Biomedical, Inc.
CLSD has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CLSD
EBIT FORECAST
EBIT Forecast Chart CLSD
NET INCOME FORECAST
Net Income Chart CLSD